Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan M Robbins

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Experimental Lung Research|November 17, 2010
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertensionIvan M Robbins, Anna R Hemnes, J Simon Gibbs, et al.
American Journal of Respiratory and Critical Care Medicine|May 27, 2006
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertensionJoy D Cogan, Michael W Pauciulo, Amy P Batchman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2022
Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipientsAnil J Trindade, Kaitlyn C Chapin, Whitney D Gannon, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2003
Sitaxsentan therapy for pulmonary arterial hypertensionRobyn J Barst, David Langleben, Adaani Frost, et al.
Journal of Clinical Medicine|October 16, 2025
The Surgical Management of Chronic Thromboembolic Pulmonary HypertensionKevin C McGann, Chen Chia Wang, John M Trahanas, et al.
Transplantation Direct|November 21, 2022
Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y PosttransplantAnil J Trindade, Kaitlyn C Chapin, Amy Mullican, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
American Heart Journal|January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized studyKelly M Chin, David B Badesch, Ivan M Robbins, et al.
Journal of the American College of Cardiology|June 25, 2003
Beraprost therapy for pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Experimental Lung Research|November 17, 2010
Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertensionIvan M Robbins, Anna R Hemnes, J Simon Gibbs, et al.
American Journal of Respiratory and Critical Care Medicine|May 27, 2006
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertensionJoy D Cogan, Michael W Pauciulo, Amy P Batchman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2022
Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipientsAnil J Trindade, Kaitlyn C Chapin, Whitney D Gannon, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2003
Sitaxsentan therapy for pulmonary arterial hypertensionRobyn J Barst, David Langleben, Adaani Frost, et al.
Journal of Clinical Medicine|October 16, 2025
The Surgical Management of Chronic Thromboembolic Pulmonary HypertensionKevin C McGann, Chen Chia Wang, John M Trahanas, et al.
Transplantation Direct|November 21, 2022
Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y PosttransplantAnil J Trindade, Kaitlyn C Chapin, Amy Mullican, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
American Heart Journal|January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized studyKelly M Chin, David B Badesch, Ivan M Robbins, et al.
Journal of the American College of Cardiology|June 25, 2003
Beraprost therapy for pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Pageof 8